Skip to main content
Clinical Trials/CTRI/2024/06/068553
CTRI/2024/06/068553Not yet recruitingPhase 3

Effectiveness Of Dhanwantara Taila Uttara Basti in The Management Of Mutrotsanga Compared With Tila Taila Uttar Basti W S R To urethral stricture A Randomized Controlled Trial - Nil

All India Institute of Ayurveda0 sites0 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
Phase 3
Status
Not yet recruiting

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • 1. Male Patients aged 20- 80 years.
  • 2. Subject diagnosed as Urethral stricture by clinical and investigative methods will be
  • 3. In uroflowmetry Qmax 3- 20 ml/s should be included.
  • 4. ICD guidelines for urethral stricture 2024 ICD-10-CM Diagnosis Code N35.91 will
  • be considered

Exclusion Criteria

  • 1,Patients having other systemic pathology like Tuberculosis, Renal Failure,
  • Uncontrolled Diabetes Mellitus And Uncontrolled Hypertension Etc..
  • 2. Patients having other urinary system pathology like severe, Nephrolithiasis,
  • BPH(Grade 3), Prostatitis
  • 3. Patients suffering from neoplasm of urinary tract.
  • 4. Patients having congenital deformity of urogenital tract
  • 5. HIV and HBsAg positive patients

Investigators

Similar Trials

Clinical trial to assess efficacy of... | Clinical Trial